Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116053113 | 11605311 | 3 | F | 2014 | 20160802 | 20151007 | 20160805 | EXP | PHHY2013CA075093 | NOVARTIS | 48.64 | YR | F | Y | 0.00000 | 20160805 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116053113 | 11605311 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY 4 WEEKS) | Y | 21008 | 30 | MG | /month | ||||||
| 116053113 | 11605311 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 40 MG, QMO (EVERY 4 WEEKS) | Y | 21008 | 40 | MG | /month | ||||||
| 116053113 | 11605311 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY 4 WEEKS) | Y | 21008 | 30 | MG | /month | ||||||
| 116053113 | 11605311 | 4 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Unknown | 8 MG, QID | Y | 0 | 8 | MG | QID | ||||||
| 116053113 | 11605311 | 5 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Unknown | 8 MG, TID | Y | 0 | 8 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116053113 | 11605311 | 1 | Pancreatic neuroendocrine tumour |
| 116053113 | 11605311 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116053113 | 11605311 | HO |
| 116053113 | 11605311 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116053113 | 11605311 | Blood pressure increased | |
| 116053113 | 11605311 | Burning sensation | |
| 116053113 | 11605311 | Crying | |
| 116053113 | 11605311 | Depression | |
| 116053113 | 11605311 | Flatulence | |
| 116053113 | 11605311 | Gout | |
| 116053113 | 11605311 | Heart rate increased | |
| 116053113 | 11605311 | Hepatic lesion | |
| 116053113 | 11605311 | Hepatic neoplasm | |
| 116053113 | 11605311 | Malignant neoplasm progression | |
| 116053113 | 11605311 | Pain in extremity | |
| 116053113 | 11605311 | Palpitations | |
| 116053113 | 11605311 | Peripheral swelling | |
| 116053113 | 11605311 | Respiratory rate increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116053113 | 11605311 | 1 | 20130318 | 0 |